`
`US010478453Bl
`
`c12) United States Patent
`Maloney et al.
`
`(10) Patent No.: US 10,478,453 Bl
`(45) Date of Patent:
`Nov. 19, 2019
`
`(54) STABLE, HIGHLY PURE L-CYSTEINE
`COMPOSITIONS FOR INJECTION AND
`METHODS OF USE
`
`(71) Applicant: Exela Pharma Sciences, LLC, Lenoir,
`NC (US)
`
`(72)
`
`Inventors: John Maloney, Salisbury, NC (US);
`Aruna Koganti, Lenoir, NC (US);
`Phanesh Koneru, Waxhaw, NC (US)
`
`(73) Assignee: Exela Pharma Sciences, LLC, Lenoir,
`NC (US)
`
`( *) Notice:
`
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`U.S.C. 154(b) by O days.
`
`(21) Appl. No.: 16/248,460
`
`(22) Filed:
`
`Jan. 15, 2019
`
`(51)
`
`(52)
`
`Int. Cl.
`A61K 9/00
`A61K 33/06
`A61K 31/191
`A61K 47102
`A61K 33/36
`A61K 331241
`A61K 33/28
`A61K 33/00
`A61K 311405
`
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2019.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(Continued)
`
`U.S. Cl.
`CPC .............. A61K 33/06 (2013.01); A23L 33/16
`(2016.08); A23L 33/175 (2016.08); A61K
`9/0029 (2013.01); A61K 31/095 (2013.01);
`A61K 31/191 (2013.01); A61K 31/198
`(2013.01); A61K 311401 (2013.01); A61K
`311405 (2013.01); A61K 3114172 (2013.01);
`A61K 33/00 (2013.01); A61K 331241
`(2019.01); A61K 33/28 (2013.01); A61K 33/36
`
`(2013.01); A61K 47102 (2013.01); A23V
`2002/00 (2013.01); A61J 1/1412 (2013.01)
`(58) Field of Classification Search
`CPC ..... A61K 9/0029; A61K 31/095; A61K 47/02
`See application file for complete search history.
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`6,992,218 B2
`7,323,206 Bl
`9,220,700 B2
`
`1/2006 Dietlin et al.
`1/2008 Driscoll et al.
`12/2015 Savarese et al.
`
`OTHER PUBLICATIONS
`
`Jalilehvand et al (Inorg. Chem., 2015, 54 (5), pp. 2160-2170). (Year:
`2015).*
`
`(Continued)
`
`Primary Examiner - Benjamin J Packard
`(74) Attorney, Agent, or Firm -Alston & Bird LLP
`
`ABSTRACT
`(57)
`The subject matter described herein is directed to stable
`L-cysteine compositions for injection, comprising: L-cyste(cid:173)
`ine or a pharmaceutically acceptable salt thereof and/or
`hydrate thereof in an amount from about 10 mg/mL to about
`100 mg/mL; Aluminum in an amount from about 1.0 parts
`per billion (ppb) to about 250 ppb; cystine in an amount
`from about 0.01 wt% to about 2 wt% relative to L-cysteine;
`pyruvic acid in an amount from about 0.01 wt % to about 2
`wt % relative to L-cysteine; a pharmaceutically acceptable
`carrier, comprising water; headspace 0 2 that is less than
`1.0%; dissolved oxygen present in the carrier in an amount
`from about 0.01 parts per million (ppm) to about 1 ppm,
`wherein the composition is enclosed in a single-use con(cid:173)
`tainer having a volume of from 10 mL to 100 mL. Also
`described are compositions for a total parenteral nutrition
`regimen and methods for their use.
`
`22 Claims, 5 Drawing Sheets
`
`-------------------------------------------------------------------------------------------------------------------------------------------------------------·
`
`Dissolved Oxygen Levels per Tray
`
`14.0
`
`12.0
`
`10.0
`
`C!!.O
`0
`
`4.0
`
`2.0
`
`0.0
`
`Final Dissolved Oxygen Post Filling -Pre HSR
`
`Post Filling - During
`
`~Trayl [
`~Tr,iy 2 :
`~-.-.»-.-.-.Tr;,y 3 [
`~Tray4 [
`~Tray 17:
`w.%._._._ Tray 18[
`~ .... ~ ... fray19:
`-Tray20[
`•.•.•.•.•.•.•.•. fray 21[
`~Tray 22:
`•.•.• ;;:;-•.•.• Tray 23 [
`
`·.:::::::;:::::. ~~:; ~~ ~
`
`········•:•.····Tray 38 [
`•·•·····:•,·,·,·Tray 39;
`•···•·.:.·•···•T;ay40[
`I
`Post HSR -Capping•
`
`·················C·o·~·p~~~~i~~ ................................................. L~a.d.in.g.~f.~y~················ Filled Vials ................ 1
`
`Nexus Ex. 1019
`Page 1 of 43
`
`
`
`US 10,478,453 Bl
`Page 2
`
`(51)
`
`Int. Cl.
`A61K 311401
`A61K 3114172
`A23L 331175
`A23L 33/16
`A61K 31/198
`A61K 31/095
`A61J 1/14
`
`(2006.01)
`(2006.01)
`(2016.01)
`(2016.01)
`(2006.01)
`(2006.01)
`(2006.01)
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Sigma-Aldrich product information, L-cysteine hydrochloride
`mononyhdrate (05/06). (Year: 2006).*
`Whiting et al (Journal of Food Protection, vol. 55, No. 1, pp. 23-27,
`Jan. 1992). (Year: 1992).*
`Lima-Rogel et al ((2016), Aluminum Contamination in Parenteral
`Nutrition Admixtures for Low-Birth-Weight Preterm Infants in
`Mexico. Journal of Parenteral andEnteral Nutrition, 40: 1014-1020)
`(Year: 2016).*
`Hintz, et al ((2008), Aluminum Exposure From Pediatric Parenteral
`Nutrition: Meeting the New FDA Regulation. JPEN J Parenter
`Enteral Nutr, 32: 242-246). (Year: 2008). *
`"Guidelines for the Use of Parenteral and Enteral Nutrition in Adult
`and Pediatric Patients," ASPEN Board of Directors and the Clinical
`Guidelines Task Force, Journal of Parenteral and Enteral Nutrition,
`26(1 Suppl.):1SA-138SA, (2002).
`"Acetadote (acetylcysteine) injection, for intravenous use: Prescrib(cid:173)
`ing Information [package insert]," Cumberland Pharmaceuticals
`Inc., 12 pages, (2017).
`"AMINOSYN [prescribing information and label]," Hospira, Inc.,
`19 pages, (2012).
`"ASHP Guidelines on the Safe Use of Automated Compounding
`Devices for the Preparation of Parenteral Nutrition Admixtures,"
`Automation and Information Technology-Guidelines, 63-67, (2000).
`"Chapter 18: Preparation of Parenteral Nutrition," Aseptic Process(cid:173)
`ing Manual, NHS Technical Specialist Education and Training
`Group, 24 pages, (2018).
`"Cysteine Hydrochloride Injection [Material Safety Data Sheet],"
`Hospira Inc., 6 pages, (2011).
`"Cysteine Hydrochloride Injection [prescribing information]," Hospira,
`Inc., 4 pages, (2004). [Retrieved from the Internet Dec. 28, 2016:
`<URL: https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrug Info.
`cfm?archiveid~ 113819>].
`"Cysteine," TOXNET: Toxicology Data Network, National Library
`of Medicine HSDB Database, 20 pages, (2016). [Retrieved from the
`Internet Jun. 27, 2017: <URL: https://toxnet.nlm.nih.gov/cgi-bin/
`sis/search/a?dbs+hsdb:@term+@DOCNO+2109>].
`"Cysteine: Pediatric drug information," Lexicomp, Inc., 4 pages,
`(1978).
`"Determination That Cysteine Hydrochloride Injection, USP, 7.25%,
`Was Not Withdrawn From Sale for Reasons of Safety or Effective(cid:173)
`ness," Federal Register, 75(107):31790-31791, (2010).
`"Effect of L-Cysteine (Acetium® Capsules) in Restoration of the
`Structure and Function of Gastric Mucosa After H. pylori Eradica(cid:173)
`tion in Patients with Atrophic Gastritis. A randomized, controlled
`trial.," Study Protocol, BIO HIT HealthCare, 45 pages, (2016).
`"Guideline on the Use of Parenteral Nutrition in Neonatal and
`Paediatric Units," Clinical Practice Guideline, Royal College of
`Physicians in Ireland, 46 pages, (2016).
`"L-Cysteine [product information]," Sigma-Aldrich, Inc., 2 pages,
`(2003).
`"L-Cysteine Hydrochloride [prescribing information and label]",
`Sandoz Inc., 6 pages, (2010).
`"L-Cysteine Hydrochloride Injection, USP [prescribing informa(cid:173)
`tion]," American Regent, Inc., 2 pages, (2009).
`"PROSOL [prescribing information and label]," Baxter Healthcare
`Corporation, 14 pages, (2014).
`"Safe Practices for Parenteral Nutrition Formulations," National
`Advisory Group on Standards and Practice Guidelines for Parenteral
`
`Nutrition, Journal of Parenteral and Enteral Nutrition, 22(2):49-66,
`(1998). [Retrieved from the Internet Mar. 12, 2015: <URL:https://
`onlinelibrary.wiley.corn/doi/10.1177 /0 l 4860719802200249>].
`"Scientific Opinion on the safety and efficacy of L-cysteine hydro(cid:173)
`chloride monohydrate as a flavouring additive for pets," European
`Food Safety Authority Journal, 11(10):3437, 13 pages, (2013).
`"The Provision of Parenteral Nutrition within Neonatal Ser(cid:173)
`vices-A Framework for Practice," British Association of Perinatal
`Medicine, 27 pages, (2016).
`"Travasol [prescribing information and label]," Baxter Healthcare
`Corporation, 19 pages, (2017).
`"Trophamine [prescribing information and label]," B. Braun Medi(cid:173)
`cal Inc., 21 pages, (2014).
`"Trophamine® (Amino Acid Injections) [package insert]," B. Braun
`Medical Inc., pp. 5-16, (2003).
`Abdulrazik et al., "Formulation for Slow Release of Oral Radiation(cid:173)
`Protection Drugs," Int. J. Nucl. Med. Biol., 11(1):53-54, (1984).
`Advenier et al., "Aluminum Contamination of Parenteral Nutrition
`and Aluminum Loading in Children on Long-Term Parenteral
`Nutrition," Journal of Pediatric Gastroenterology and Nutrition,
`36(4):448-453, (2003). [Retrieved from the Internet Jun. 6, 2018:
`<URL: https://joumals.lww.corn/jpgn/Fulltext/2003/04000/ Aluminum_
`Contamination_of _Parenteral_Nutrition_and.5 .aspx#pdf-link>].
`Allen, Jr., Loyd V., "L-Cysteine Hydrochloride 50 mg/mL Injec(cid:173)
`tion," U.S. Pharmacist, 36(9):41-42, (2011). [Retrieved from the
`Internet May 26, 2016: <URL:https://www.uspharmacist.com/article/
`lcysteinehydrochloride50mgrnlinjection> ].
`Allen, Loyd V., "Chapter 1: Guidelines for Compounding Prac(cid:173)
`tices," The Art, Science, and Technology of Pharmaceutical Com(cid:173)
`pounding, 4th Ed.:1-18, (2012).
`Allwood et al., "Compatibility and Stability of Additives in Parenteral
`Nutrition Admixtures," Nutrition, 14(9):697-706, (1998).
`Anderson et al., "Physical Compatibility of Calcium Chloride and
`Sodium Glycerophosphate in Pediatric Parenteral Nutrition Solu(cid:173)
`tions," Journal of Parenteral and Enteral Nutrition, 40(8): 1166-
`1169, (2016, Epub. 2015). [Retrieved from the Internet Oct. 24,
`2015: <URL: https://onlinelibrary.wiley.com/doi/epdf/10.1177 /
`0148607115592673>].
`Ayers et al., "A.S.P.E.N. Parenteral Nutrition Safety Consensus
`Recommendations," Scholarship and Professional Work-COPHS,
`Butler University, 66 pages, (2014).
`Baines et al., "The Association Between Cysteine, Bone Turnover,
`and Low Bone Mass," Calcif Tissue Int, 81(6):450-454, (2007).
`Balogh, Judit Kovacsne, "Preparation and examination of TPN
`systems for the individual clinical therapy," (Ph.D. Thesis), Sem(cid:173)
`melweis University, Hungary, 116 pages, (2007).
`Bengoa et al., "Amino acid-induced hypercalciuria in patients on
`total parenteral nutrition," The American Journal of Clinical Nutri(cid:173)
`tion, 38(2):264-269, (1983). [Retrieved from the Internet Dec. 14,
`2017: <URL: https://academic.oup.corn/ajcn/article-abstract/38/2/
`264/4690894>].
`Bettner et al., "Effects of pH, Temperature, Concentration, and Time
`on Particle Counts in Lipid-Containing Total Parenteral Nutrition
`Admixtures," Journal of Parenteral andEnteral Nutrition, 10(4):375-
`380, (1986). [Retrieved from the Internet Mar. 10, 2015: <URL:
`https :// onlinelibrary. wiley.com/ doi/ epdf/ 10 .11 77 /
`0148607186010004375>].
`Bishop et al., "Aluminum Neurotoxicity in Preterm Infants Receiv(cid:173)
`ing Intravenous-Feeding Solutions," The New England Journal of
`Medicine, 336(22):1557-1561, (1997). [Retrieved from the Internet
`Jun. 5, 2018: <URL: https://www.nejm.org/doi/full/10.1056/
`NEJM199705293362203>].
`Bistrian, Bruce R., "Brief History of Parenteral and Enteral Nutri(cid:173)
`tion in the Hospital in the USA," Nestle Nutr Inst Workshop Ser
`Perform Program, 12:127-136, (2009).
`Bjelton et al., "Availability of Cysteine and ofL-2-0xo-Thiazolidine-
`4-Carboxylic Acid as a Source of Cysteine in Intravenous Nutri(cid:173)
`tion," Journal of Parenteral and Enternal Nutrition, 14(2):177-182,
`(1990).
`Bohrer et al., Aluminum Loading in Preterm Neonates Revisited,
`JPGN, 51(2):237-241, (2010).
`
`Nexus Ex. 1019
`Page 2 of 43
`
`
`
`US 10,478,453 Bl
`Page 3
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Borges-Santos et al., "Plasma glutathione of HIV+ patients responded
`positively and differently to dietary supplementation with cysteine
`or glutamine," Nutrition, 28(7-8):753-756, (2012).
`Boullata et al., "A.S.P.E.N. Clinical Guidelines: Parenteral Nutrition
`Ordering, Order Review, Compounding, Labeling, and Dispens(cid:173)
`ing," Journal of Parenteral and Enteral Nutrition, 38(3):334-377,
`(2014).
`Brigham et al., "The Concentrations of Cysteine and Cystine in
`Human Blood Plasma," J Clin Invest., 39(11):1633-1638, (1960).
`Brown et al., "Potential Aluminum Exposure from Parenteral Nutri(cid:173)
`tion in Patients with Acute Kidney Injury," The Annals of
`Pharmacotherapy, 42(10):1410-1415, (2008).
`Bulbul et al., "Letter to the Editor: Nutritional support in preterm
`infants," Pediatrics and Neonatology, 58(6):562, (2017).
`Bullock et al., "Emulsion Stability in Total Nutrient Admixtures
`Containing a Pediatric Amino Acid Formulation," Journal of Parenteral
`and Enteral Nutrition, 16(1):64-68, (1992). [Retrieved from the
`Internet Feb. 10, 2015: <URL: https://onlinelibrary.wiley.com/doi/
`pdf/10.1177/014860719201600164>].
`Calkins et al., "Effect of High-Dose Cysteine Supplementation on
`Erythrocyte Glutathione: a Double-Blinded, Randomized Placebo
`Controlled Pilot Study in Critically III Neonates," JPEN J Parenter
`Enteral Nutr., 40(2):226-234, (2016).
`Carlson et al., "Neonatal Parenteral and Enteral Nutrition: A Resource
`Guide for the Student and Novice Neonatal Nurse Practitioner,"
`National Association of Neonatal Nurse Practitioners, 23 pages,
`(2010).
`Connelly et al., "Congenital Hypothyroidism Caused by Excess
`Prenatal Maternal Iodine Ingestion," The Journal of Pediatrics,
`161(4):760-762, (2012).
`Courtney-Martin et al., "Plasma Aluminum Concentrations in Pedi(cid:173)
`atric Patients Receiving Long-Term Parenteral Nutrition," Journal
`of Parenteral and Enteral Nutrition, 39(5):578-585, (2014).
`Courtney-Martin et al., "The Addition of Cysteine to the Total
`Sulphur Amino Acid Requirement as Methionine Does Not Increase
`Erythrocytes Glutathione Synthesis in the Parenterally Fed Human
`Neonate," Pediatric Research, 67(3):320-324, (2010).
`Darkwa et al., "Antioxidant Chemistry: Oxidation of L-Cysteine
`and Its Metabolites by Chlorite and Chlorine Dioxide," J. Phys.
`Chem. A., 108(26):5576-5587, (2004).
`De Cloet et al., "Physicochemical stable standard all-in-one parenteral
`nutrition admixtures for infants and children in accordance with the
`ESPGHAN/ESPEN guidelines," Nutrition, 49:41-47, (2018).
`Delange, F., "Optimal Iodine Nutrition during Pregnancy, Lactation
`and the Neonatal Period," Int J Endocrinol Metab, 2(1)1-12, (2004).
`Delange, Francois, "Iodine deficiency in Europe and its conse(cid:173)
`quences: an update," Eur J Nucl Med, 29(Suppl. 2):S404-S416,
`(2002).
`Delange, Francois, "Iodine requirements during pregnancy, lacta(cid:173)
`tion and the neonatal period and indicators of optimal iodine
`nutrition," Public Health Nutrition: 10(12A):1571-1580, (2007).
`Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat,
`Fatty Acids, Cholesterol, Protein, and Amino Acids, The National
`Academies Press, 1358 pages, (2002). [Retrieved from the Internet
`Dec. 12, 2017: <URL: http://www.nap.edu/10490>].
`Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic,
`Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,
`Nickel, Silicon, Vanadium, and Zinc, National Academy Press, 800
`pages, (2000). [Retrieved from the Internet Dec. 16, 2018: <URL:
`http://www.nap.edu/catalog/ 10026.htrnl>].
`Dilger et al., "Excess Dietary L-Cysteine, but Not L-Cystine, Is
`Lethal for Chicks but Not for Rats or Pigs," The Journal of
`Nutrition, 137(2):331-338, (2007). [Retrieved from the Internet Jun.
`28, 2017: <URL:https://academic.oup.com/jn/article/137 /2/331/
`4664534>].
`Domingo et al., "Risks of aluminium exposure during pregnancy,"
`Contributions to Science, 1(4):479-487, (2000).
`Dumortier et al., "Development of a Thermogelling Ophthalmic
`Formulation of Cysteine," Drug Development and Industrial Phar-
`
`macy, 32(1):63-72, (2006). [Retrieved from the Internet May 12,
`2015: <URL: https://www.tandfonline.com/doi/full/l 0.1080/
`03639040500390934>].
`El-Shenawy et al., "Nephrotoxicity of sodium valproate and pro(cid:173)
`tective role of L-cysteine in rats at biochemical and histological
`levels," J Basic Clin Physiol Pharmacol, 27(5):497-504, (2016).
`[Retrieved from the Internet May 4, 2016: <URL: https://www.
`degruyter.com/view/j/jbcpp.2016.27.issue-5/jbcpp-2015-0106/jbcpp-
`2015-0106 .xml>].
`Fewtrell et al., "Aluminium exposure from parenteral nutrition in
`preterm infants and later health outcomes during childhood and
`adolescence," Symposium 2: Micronutirents under the Microscope,
`Proceedings of the Nutrition Society, 70(3):299-304, (2011 ). [Retrieved
`from the Internet Jun. 4, 2018: <URL: https://www.cambridge.org/
`core/journals/proceedings-of-the-nutrition-society/article/aluminium(cid:173)
`expo sure-from -parenteral-nutrition -in -preterm-inf ants-and-later(cid:173)
`heal th -outcomes -during -childhood- and- ado le s c enc e /
`F5D0A6 l 096 l 6E8C9D7F8C2C7072 l 3860/ core-reader>].
`Flora et al., "Chelation in Metal Intoxication," Int. J. Environ. Res.
`Public Health, 7(7):2745-2788, (2010).
`Fortenberry et al., "Evaluating Differences in Aluminum Exposure
`through Parenteral Nutrition in Neonatal Morbidities," Nutrients,
`9(11):El249, 6 pages, (2017).
`Frey et al., "Confirming the Causative Role of Acetaminophen in
`Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine
`Adducts," J. Med. Toxicol., 11(2):218-222, (2015).
`Furst et al., "Parenteral nutrition by a solution of crystalline amino
`acids," Acta Med Scand Suppl., 472:283-293, (1967).
`Fusch et al., "Neonatology/Paediatrics----Guidelines on Parenteral
`Nutrition, Chapter 13," GMS German Medical Science, 7(Doc15):23
`pages, (2009).
`Ghirri et al., "Iodine Supplementation in the Newborn," Nutrients,
`6(1):382-390, (2014).
`Gura et al., "Aluminum contamination in products used in parenteral
`nutrition: Has anything changed?," Nutrition, 26(6):585-594, (2010).
`Gura et al., "Recent developments in aluminium contamination of
`products used in parenteral nutrition," Curr Opin Clin Nutr Metab
`Care, 9(3):239-246, (2006).
`Hardy et al., "Formulation, Stability, and Administration of Parenteral
`Nutrition With New Lipid Emulsions," Nutrition in Clinical Prac(cid:173)
`tice, 24(5):616-625, (2009).
`Hardy et al., "P.83: Stability of aqueous cysteine solutions for TPN
`[Abstract]," Clinical Nutrition, 12(Suppl 2):61, (1993).
`Harman et al., "Free Radical Metabolites ofL-Cysteine Oxidation,"
`The Journal of Biological Chemistry, 259(9):5606-5611, (1984).
`[Retrieved from the Internet Feb. 6, 2017: <URL: http://www.jbc.
`org/content/259/9/5606.full.pdf>].
`Heird et al., "Pediatric Parenteral Amino Acid Mixture in Low Birth
`Weight Infants," Pediatrics, 81(1):41-50, (1988). [Retrieved from
`the Internet Dec. 8, 2017: <URL: http:/ /pediatrics.aappublications.
`org/content/8111/41>].
`Hellstrom et al., "Sal863. L-Cysteine Slow-Release Capsule For(cid:173)
`mulation in Prevention of Gastric Carcinogenesis Associated With
`Atrophic Gastritis," AGAAbstracts, 146(5, Suppl l):S-315, (2014).
`Helms et al., "Cysteine supplementation results in normalization of
`plasma taurine concentrations in children receiving home parenteral
`nutrition," J Pediatr, 134(3):358-361, (1999).
`Hernandez-Sanchez et al., "Aluminium in parenteral nutrition: a
`systematic review," European Journal of Clinical Nutrition, 67(3):230-
`238, (2013).
`Heyman et al., "Aluminum Does Not Accumulate in Teenagers and
`Adults on Prolonged Parenteral Nutrition Containing Free Amino
`Acids," Journal of Parenteral and Enteral Nutrition, 10(1):86-87,
`(1986).
`Ho et al., "Trend of Nutritional Support in Preterm Infants,"
`Pediatrics and Neonatology, 57(5):365-370, (2016).
`Hu et al., "Efficacy and safety of acetylcysteine in "non(cid:173)
`acetaminophen" acute liver failure: A meta-analysis of prospective
`clinical trials," Clin Res Hepatol Gastroenterol, 39(5):594-599,
`(2015).
`Hulst, Jessie, "Principles of feeding the preterm infant," 36th
`ESPEN Congress, Geneva, 44 pages, (2014).
`
`Nexus Ex. 1019
`Page 3 of 43
`
`
`
`US 10,478,453 Bl
`Page 4
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Huston et al., "Calcium Chloride in Neonatal Parenteral Nutrition
`Solutions with and without Added Cysteine: Compatibility Studies
`Using Laser and Micro-Flow Imaging Methodology," PLoS ONE,
`10(8):eO 136894, (2015).
`Huston et al., "Calcium chloride in neonatal parenteral nutrition: A
`15 year experience," Journal of Neonatal-Perinatal Medicine, 10(1):33-
`38, (2017).
`Huston et al., "Calcium Chloride in Neonatal Parenteral Nutrition:
`Compatibility Studies Using Laser Methodology," PLoS ONE,
`9(9):el06825, (2014).
`Ishii et al., "A case of drug-induced ductopenia resulting in fatal
`biliarv cirrhosis," Liver, 13(4):227-231, (1993).
`Ishii et al., "Cystathionine y-Lyase-deficient Mice Require Dietary
`Cysteine to Protect against Acute Lethal Myopathy and Oxidative
`Injury," The Journal of Biological Chemistry, 285(34):26358-
`26368, (2010).
`Jadhav et al., "Parenteral Amino Acid and Metabolic Acidosis in
`Premature Infants," JPEN J Parenter Enteral Nutr., 31(4):278-283,
`(2007).
`Janakyet al., "Mechanisms ofL-Cysteine Neurotoxicity," Neurochemi(cid:173)
`cal Research, 25(9/10):1397-1405 (2000).
`Ji et al., "Excessive L-cysteine induces vacuole-like cell death by
`activating endoplasmic reticulum stress and mitogen-activated pro(cid:173)
`tein kinase signaling in intestinal porcine epithelial cells," Amino
`Acids, 48( 1 ): 149-156, (2015).
`John et al., "Total parenteral nutrition usage trends in the United
`States," Journal of Critical Care, 40:312-313, (2017).
`Kartal et al., "Compatibility of chewing gum excipients with the
`amino acid L-cysteine and stability of the active substance in
`directly compressed chewing gum formulation," Journal of Phar(cid:173)
`macy and Pharmacology, 60(9):1131-1138, (2008).
`Kartal et al., "Formulation and in-vivo evaluation of L-cysteine
`chewing gums for binding carcinogenic acetaldehyde in the saliva
`during smoking," Journal of Pharmacy and Pharmacology, 59( 10): 1353-
`1358, (2007).
`Kartal-Hodzic, Alma, "Formulation studies for eliminating saliva
`carcinogenic acetaldehyde with L-cysteine containing chewing gum,"
`(Academic Dissertation), Division of Biopharmaceutics and
`Pharrnacokinetics, University of Helsinki, Finland, 60 pages, (2012).
`Klein et al., "Hypocalcemia Complicating Deferoxamine Therapy
`in an Infant with Parenteral Nutrition-Associated Aluminum Over(cid:173)
`load: Evidence for a Role of Aluminum in the Bone Disease of
`Infants," Journal of Pediatric Gastroenterology and Nutrition, 9(3):400-
`403, ( 1989). [Retrieved from the IntemetJun. 5, 2018: <URL:https://
`journals .lww.com/jpgn/ Abstract/ 1989/ 10000/Hypocalcemia_
`Complicating_Deferoxamine_ Therapy _in.24.aspx>].
`Klein, Catherine J., "Nutrient Requirements For Preterm Infant
`Formulas," The Journal of Nutrition, 132(6 Suppl l):1395S-1577S,
`(2002). [Retrieved from the Internet Dec. 6, 2017: <URL: http://
`jn.nutrition.org>].
`Kolaric et al., "Solutions Preparing for Total Parenteral Nutrition for
`Children," Proceedings of the 7th WSEAS International Conference
`on Mathematics & Computers in Biology & Chemistry, Cavtat,
`Croatia, 6 pages, (2006).
`Koletzko et al., "Guidelines on Paediatric Parenteral Nutrition: 3.
`Amino Acids," J. Pediatr. Gastroenterol. Nutr., 4l(Suppl. 2):Sl2-
`Sl8, (2005).
`Komura et al., "Increased Incidence of Cholestasis during Total
`Parenteral Nutrition in Children," The Kurume Medical Journal,
`40(1):7-11, (1993).
`Koo et al., "Response to aluminum in parenteral nutrition during
`infancy," The Journal of Pediatrics, 109(5):877-883, (1986).
`Laine et al., "Cysteine usage increases the need for acetate in
`neonates who receive total parenteral nutrition," The American
`Journal of Clinical Nutrition, 54(3):565-567, (1991). [Retrieved
`from the Internet Apr. 14, 2015: <URL: https://academic.oup.corn/
`ajcn/article-abstract/ 54/3/ 565/4694399>].
`Lapillonne et al., "Quality of newborn care: adherence to guidelines
`for parenteral nutrition in preterm infants in four European coun-
`
`tries," BMJ Open, 3(9):E003478, 8 pages, (2013). [Retrieved from
`the Internet Jun. 6, 2018: <URL: https://bmjopen.bmj.corn/content/
`3/9/e003478>].
`Larchet et al., "Aluminium Loading in Children Receiving Long(cid:173)
`term Parenteral Nutrition," Clinical Nutrition, 9(2):79-83, (1990).
`Lee et al., "AASLD Position Paper: The Management of Acute
`Liver Failure: Update 2011," Hepatology, 1-22 and Corrections,
`(2011).
`Lee et al., "Introduction to the Revised American Association for the
`Study of Liver Diseases Position Paper on Acute Liver Failure
`2011," Hepatology, 55(3):965-967, (2012).
`Leung et al., "Consequences of excess iodine," Nat Rev Endocrinol.,
`10(3):136-142, (2014).
`Leyden et al., "Stabilization of Solutions of Cysteine and its
`Derivatives," Can. J. Biochem., 45(4):611-614, (1967). [Retrieved
`from the Internet Nov. 12, 2014: <URL: https://www.nrcresearchpress.
`corn/doi/pdf/10.1139/067-071>].
`Li et al., "Acute and sub-chronic toxicity of glucose----cysteine
`Maillard reaction products in Sprague-Dawley rats," Food and
`Chemical Toxicology, 80:271-276, (2015).
`Look et al., "Is the Increase in Serum Cystathionine Levels in
`Patients with Liver Cirrhosis a Consequence of Impaired Homocysteine
`Transsulfuration at the Level of y-Cystathionase?," Scand J
`Gastroenterol, 35(8):866-872, (2000). [Retrieved from the Internet
`Oct. 25, 2014: <URL: https://www.tandfonline.com/doi/abs/10.1080/
`003655200750023255>].
`Mackay et al., "Physical Compatibility of Sodium Glycerophosphate
`and Calcium Gluconate in Pediatric Parenteral Nutrition Solutions,"
`JPEN J Parenter Enteral Nutr, 39(6):725-728, (2015, Epub. 2014).
`[Retrieved from the Internet Apr. 6, 2014: <URL: http:/ /pen.sagepub.
`corn/content/early/2014/03/31/0148607114528982>].
`Mackay et al., "The Solubility of Calcium and Phosphate in Two
`Specialty Amino Acid Solutions," Journal of Parenteral and Enteral
`Nutrition, 20( 1 ):63-66, ( 1996). [Retrieved from the Internet Apr. 17,
`2015: <URL: https://onlinelibrary.wiley.com/doi/epdf/10.1177 /
`014860719602000163>].
`Malloy et al., "Cyst( e )ine measurements during total parenteral
`nutrition," The American Journal of Clinical Nutrition, 37(2):188-
`191, (1983). [Retrieved from the Internet Apr. 14, 2015: <URL:
`https :// academic .oup .com/ aj en/ article-abstract/3 7 /2/ 188/
`4690722>].
`Malloy et al., "Cysteine Supplementation During Total Parenteral
`Nutrition (TPN) [Abstract]," Clinical Nutrition, l(Suppl.):49, (1982).
`Malloy et al., "Cysteine Supplementation of Total Parenteral Nutri(cid:173)
`tion: the Effect in Beagle Pups," Pediatric Research, 18(8):747-751,
`(1984).
`Malloy et al., "Total Parenteral Nutrition in Sick Preterm Infants:
`Effects of Cysteine Supplementation with Nitrogen Intakes of 240
`and 400 mg/kg/day," Journal of Pediatric Gastroenterology and
`Nutrition, 3(2):239-244, (1984).
`Manz, Friedrich, "L-Cysteine in metabolic acidosis of low-birth(cid:173)
`weight infants," Am J Clin Nutr, 57(3):455-456, (1993). [Retrieved
`from the Internet Apr. 16, 2015: <URL: https://academic.oup.corn/
`ajcn/article-abstract/57 /3/455/4715721>].
`Mattox et al., "Chapter 142: Parenteral Nutrition," Pharmacotherapy:
`A Pathophysiologic Approach, lOe, McGraw Hill, Ed. Joseph T.
`DiPiro et al., 38 pages, (2016). [Retrieved from the Internet Dec. 5,
`2017: <URL: https://accesspharmacy.mhrnedical.corn/content.aspx?
`bookid~ 186 l§ionid~ 146076679>].
`McCarthy et al., "Standardised versus Individualized Parenteral
`Nutrition," Irish Medical Journal, 109(4): 10 pages, (2016). [Retrieved
`from the Internet Jun. 6, 2018: <URL: http://imj.ie/standardised(cid:173)
`versus-indi v iduali sed-paren teral-n utri ti on -further-food- for(cid:173)
`thought/>].
`McClave et al., "Guidelines for the Provision and Assessment of
`Nutrition Support Therapy in the Adult Critically Ill Patient: Society
`of Critical Care Medicine (SCCM) and American Society for
`Parenteral and Enteral Nutrition (A.S.P.E.N.)," Journal of Parenteral
`and Enteral Nutrition, 40(2):159-211, (2016).
`Metabolic Processes in the Foetus and Newborn Infant, Nutricia
`Symposium, Ed. J. H. P. Jonxis et al., H. E. Stenfert Kroese N.V.,
`317 pages, (1971).
`
`Nexus Ex. 1019
`Page 4 of 43
`
`
`
`US 10,478,453 Bl
`Page 5
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Miller et al., "Decreased Cysteine and Pro line Synthesis in Parenter(cid:173)
`ally Fed, Premature Infants," Journal of Pediatric Surgery, 30(7):953-
`958, (1995).
`Miller, Sarah J., "Parenteral Nutrition," U.S. Pharmacist, 7(HS10-
`HS20):31 pages, (2006). [Retrieved from the Internet Sep. 26, 2018:
`<URL: https://www.uspharmacist.com/ article/parenteral(cid:173)
`nutrition>].
`Mirtallo et al., "Safe Practices for Parenteral Nutrition," Journal of
`Parenteral and Enteral Nutrition, 28(6):S39-S70, (2004). [Retrieved
`from the Internet Jan. 23, 2014: <URL: https://journals.sagepub.
`corn/doi/abs/10.1177/0148607104028006s39>].
`Moreno et al., "Aluminium in the neonate related to parenteral
`nutrition," Acta Paediatr, 83(1):25-29, (1994).
`Moreno Villares et al., "Current use of parenteral nutrition in a
`pediatric hospital. Comparison to the practise 8 years ago," Nutr.
`Hosp., 20(1):46-51, (2005).
`Miihlebach, Stefan, "Parenteral Nutrition: The Role of the Pharma(cid:173)
`cist in the Era of 3-chamber Bags," 27th ESPEN Congress, Brus(cid:173)
`sels, 49 pages, (2005).
`Mundi et al., "Prevalence of Home Parenteral and Enteral Nutrition
`in the United States [Abstract]," Nutr Clin Pract., 32(6):799-805,
`(2017). [Retrieved from the Internet Jun. 6, 2018: <URL: http://
`journals.sagepub.corn/doi/pdf/ 10.1177 /0884533617718472>].
`Murphy et al., "Annual Summary of Vital Statistics: 2013-2014,"
`Pediatrics, 139(6):e20163239, (2017). [Retrieved from the Internet
`Jun. 6, 2018: <URL: http:/ /pediatrics.aapublications.org/content/
`139/6/e20163239>].
`Nguyen et al., "Effect of Increasing Glutathione With Cysteine and
`Glycine Supplementation on Mitochondrial Fuel Oxidation, Insulin
`Sensitivity, and Body Composition in Older HIV-Infected Patients,"
`J Clin Endocrinol Metab,, 99(1):169-177, (2014). [Retrieved from
`the Internet Dec. 12, 2017: <URL: https://academic.oup.corn/jcern/
`article-abstract/99/1/169/2836223>].
`Niermeyer et al., "Optimized calcium/phosphorus solubility in a
`parenteral nutrition solution containing dicarboxylic amino acids
`and cysteine," Journal of the American College of Nutrition, 5(5):459-
`466, (1986). [Retrieved from the Internet Apr. 21, 2015: <URL:
`https://www.tandfonline.com/doi/pdf/ 10.1080/07315724.1986.
`10720149>].
`Nishiyama et al., "Transient Hypothyroidism or Persistent
`Hyperthyrotropinemia in Neonates Born to Mothers with Excessive
`Iodine Intake," Thyroid, 14(2): 1077-1083, (2004).
`Olney et al., "Brain Damage in Infant Mice following Oral Intake
`of Glutamate, Aspartate or Cysteine," Nature, 227(5258):609-611,
`(1970).
`0 'N ea! et al., "Compliance with safe practices for preparing parenteral
`nutrition formulations," Am J Health Syst Pharm, 59(3):264-269,
`(2002).
`Parikh et al., "Physical compatibility of neonatal total parenteral
`nutrient admixtures containing organic calcium and inorganic phos(cid:173)
`phate salts," Am J Health Syst Pharm, 62(11): 1177-1183, (2005).
`Patanwala et al., "Antiemetic Therapy for Nausea and Vomiting in
`the Emergency Department," The Journal of Emergency Medicine,
`39(3):330-336, (2010).
`Patel et al., "Total parenteral nutrition for premature infants: prac(cid:173)
`tice aspects," Journal of Nature and Science (JNSCI), 3(1):e301, 6
`pages, (2017).
`Patt et al., "Cysteine Protection against X Irradiation," Science,
`110(2852):213-214, (1949).
`Paulikova et al., "Iodine toxicity in ruminants," Vet. Med.-Czech,
`47(12):343-350, (2002).
`Pertkiewicz et al., "Basics in clinical nutrition: Stability of parenteral
`nutrition admixtures," e-Spen, the European e-Journal of Clinical
`Nutrition and Metabolism, 4(3):ell 7-ell9, (2009).
`Plogsted et al., "Parenteral Nutrition L-Cysteine Product Shortage
`Considerations," Nutrition in Clinical Practice, 30( 4):579-580, (2015).
`Poole et al., "Aluminum Exposure From Pediatric Parenteral Nutri(cid:173)
`tion: Meeting the New FDA Regulation," Journal of Parenteral and
`Enteral Nutrition, 32(3):242-246, (2008).
`
`Poole et al., "Aluminum Exposure in Neonatal Patients Using the
`Least Contaminated Parenteral Nutrition Solution Products," Nutri(cid:173)
`ents, 12(4):1566-1574, (2012).
`Pyati et al., "Absorption of iodine in the neonate following topical
`use of povidone iodine," The Journal of Pediatrics, 91(5):825-828,
`(1977).
`Rabbani et al., "Glycation research in amino acids: a place to call
`home," Amino Acids, 42:1087-1096, (2012). [Retrieved from the
`Internet May 10, 2016: <URL: https://www.researchgate.net/
`publication/47 567399>].
`Rassin, David Keith, "Essential and Non-essentia